Markers for the identification of late breast cancer recurrence.
about
Prospective Validation of a 21-Gene Expression Assay in Breast CancerUse of the concordance index for predictors of censored survival data.Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.The recurrence frequency of breast cancer and its prognostic factors in Iranian patients.The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
P2860
Q29011698-9539B10B-E0B2-4C7C-B64D-A3E97FF3E6F7Q31147068-2591872A-D390-4E72-85E1-6B87C4E82005Q36353524-361D2965-303C-4748-B72F-EE17ED69E1EAQ37059543-AFA47865-FF13-40C8-B0D8-209EE303DAB9Q37668443-1E57E6B7-24F5-4DE7-AC4A-FBFAE1C05161Q38510960-98537991-1F73-456B-BD28-462906CC15EEQ38933874-33A9543C-01B5-4FD8-A3E1-EA58D59CC30BQ39454318-56AEAC8F-5677-4181-AB63-CB5BF89E11F4Q40043175-20DB9044-82A4-45CC-80F2-D7ADB0F26C26Q40546472-455EE39B-61D0-4DC0-A061-9A6115A525F4Q40581595-BFDAB6CA-84B4-4D35-AA96-0E8CD7E30B89Q42355178-02D7F4FB-B689-46EA-B1DC-4FA4F16C73B9Q47204606-27A183E2-6BDE-4D32-8059-D9461DC4E507Q55009101-434427CB-3B02-4BDD-A556-360DF98DE55EQ55280867-D3829F39-D651-4ED8-8017-419C8B61A155
P2860
Markers for the identification of late breast cancer recurrence.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Markers for the identification of late breast cancer recurrence.
@ast
Markers for the identification of late breast cancer recurrence.
@en
type
label
Markers for the identification of late breast cancer recurrence.
@ast
Markers for the identification of late breast cancer recurrence.
@en
prefLabel
Markers for the identification of late breast cancer recurrence.
@ast
Markers for the identification of late breast cancer recurrence.
@en
P2860
P921
P1476
Markers for the identification of late breast cancer recurrence.
@en
P2093
Ivana Sestak
Jack Cuzick
P2860
P2888
P356
10.1186/S13058-015-0516-0
P5008
P577
2015-01-27T00:00:00Z
P5875
P6179
1023339396